As of 2026-03-20, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (25.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.89 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -623.8%.
The range of the Relative Valuation is (22.93) - (26.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 22.9x | 20.6x |
| Forward P/E multiples | 17.8x - 21.6x | 21.0x |
| Fair Price | (22.93) - (26.60) | (25.61) |
| Upside | -568.9% - -643.9% | -623.8% |
| Date | P/E |
| 2026-03-17 | -4.11 |
| 2026-03-16 | -4.04 |
| 2026-03-13 | -3.98 |
| 2026-03-12 | -4.00 |
| 2026-03-11 | -4.59 |
| 2026-03-10 | -4.46 |
| 2026-03-09 | -4.45 |
| 2026-03-06 | -4.69 |
| 2026-03-05 | -4.58 |
| 2026-03-04 | -4.60 |
| 2026-03-03 | -4.48 |
| 2026-03-02 | -4.68 |
| 2026-02-27 | -4.61 |
| 2026-02-26 | -4.68 |
| 2026-02-25 | -4.71 |
| 2026-02-24 | -4.60 |
| 2026-02-23 | -4.67 |
| 2026-02-20 | -4.65 |
| 2026-02-19 | -4.73 |
| 2026-02-18 | -4.60 |
| 2026-02-17 | -4.52 |
| 2026-02-13 | -4.51 |
| 2026-02-12 | -4.27 |
| 2026-02-11 | -4.40 |
| 2026-02-10 | -4.43 |
| 2026-02-09 | -4.43 |
| 2026-02-06 | -4.61 |
| 2026-02-05 | -4.25 |
| 2026-02-04 | -4.57 |
| 2026-02-03 | -4.62 |
| 2026-02-02 | -4.75 |
| 2026-01-30 | -4.64 |
| 2026-01-29 | -4.69 |
| 2026-01-28 | -4.77 |
| 2026-01-27 | -4.79 |
| 2026-01-26 | -4.72 |
| 2026-01-23 | -4.78 |
| 2026-01-22 | -5.03 |
| 2026-01-21 | -4.94 |
| 2026-01-20 | -4.52 |
| 2026-01-16 | -4.89 |
| 2026-01-15 | -5.10 |
| 2026-01-14 | -5.12 |
| 2026-01-13 | -5.42 |
| 2026-01-12 | -5.18 |
| 2026-01-09 | -4.19 |
| 2026-01-08 | -4.25 |
| 2026-01-07 | -4.27 |
| 2026-01-06 | -4.00 |
| 2026-01-05 | -4.04 |